Search clinical trials for: C-type natriuretic peptide

Total 5063 results

Heidelberg University

Unknown

High Sensitive Troponin T (hsTnT) and Copeptin as Prognostic Parameters in Patients With Elective Total Endoprosthesis

Pulmonary Embolism | Perioperative Myocardial Infarctions

Germany
Peking Union Medical College Hospital

Completed

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China (SMART)

Stroke

China
Hadassah Medical Organization
Hebrew University of Jerusalem

Unknown

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior

Healthy

Israel
Sanofi
Bristol-Myers Squibb

Completed

I PREVENT - Irbesartan In Hypertensive Diabetic Patients

Hypertension

Egypt
Novartis

Completed

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population (ACTION)

Hypertension

United States
Sanofi
Bristol-Myers Squibb

Completed

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

Hypertension

Egypt
Georgetown University
University of Virginia

Completed

Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet (Salt)

Salt-sensitive Hypertension

United States
Yonsei University

Completed

Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension

Essential Hypertension

Korea, Republic of
Novartis Pharmaceuticals

Completed

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

Hypertension

United States
University of Aarhus

Completed

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

Healthy

Denmark
Novartis

Completed

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension (ATTAIN)

Hypertension

United States
Novartis

Completed

Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension (AIMS)

Hypertension

United States
Novartis

Completed

An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

Hypertension

United States, Belgium, Denmark, Finland, Germany, Iceland, India, Switzerland
Chulalongkorn University

Unknown

The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients

Peritoneal Membrane Failure

Thailand
Novartis

Completed

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension (EXALT)

Stage 2 Systolic Hypertension

United States
Kyushu University

Completed

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial (COMFORT)

Hypertension

Japan
University Children's Hospital Tuebingen
University of Ulm; Universität Duisburg-Essen

Unknown

Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo (APA-IIb)

Pneumonia | Cystic Fibrosis

Germany
Assistance Publique - Hôpitaux de Paris

Completed

PHARES Study: Management of Resistant Hypertension

Hypertension

France
University Medical Center Groningen
ISA Pharmaceuticals B.V.; Dutch Cancer Society

Completed

p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer (ISA-P53-CTX)

Ovarian Cancer

Netherlands
University Hospital, Basel, Switzerland

Completed

Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides

Taste Disorder, Secondary, Sweet

Switzerland
Peking Union Medical College Hospital

Completed

Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis (ESSCAS)

Stroke | Atherosclerosis | Transient Ischemic Attack | Stenosis | Stents

China
University Hospital, Basel, Switzerland

Completed

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Appetite and General Nutritional Disorders | Hormone Replacement

Switzerland
Glostrup University Hospital, Copenhagen

Completed

GLP-2 (Glucagonlike Peptide-2) and Blood Flow

Regional Blood Flow

Denmark
University of Campinas, Brazil

Completed

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

Diabetes Mellitus, Type 2 | Insulin Resistance

Brazil
Hvidovre University Hospital

Completed

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

Type-1 Diabetes Mellitus

Denmark
University Hospital, Gentofte, Copenhagen
The Novo Nordic Foundation; Aase and Ejnar Danielsens Foundation; The Danish...

Completed

Study of Postprandial Incretin Response in Women With Gestational Diabetes

Gestational Diabetes Mellitus

Denmark
Karolinska Institutet

Unknown

Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis (BAS)

Diabetes Mellitus Type 1

Sweden
University of Yamanashi
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Esophageal Cancer

Japan
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Sarcoma | Brain and Central Nervous System Tumors | Gastrointestinal Stromal Tumor

United States
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Pancreatic Cancer

Japan
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
Taipei Medical University WanFang Hospital

Completed

Comparison of Anterior Chamber Paracentesis and Conventional Mannitol Infusion in Patients With Primary Acute Angle-closure Glaucoma

Glaucoma | Acute Primary Angle-closure Glaucoma

Taiwan
Johannes Gutenberg University Mainz

Terminated

Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease (DEPOPA)

Parkinson Disease

Germany
AstraZeneca

Completed

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

Hypertension

Russian Federation, Latvia, Romania, Slovakia, Belgium, Malta
Sankyo Pharma Gmbh

Completed

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension (OLMETREAT)

Essential Hypertension

France, Austria, Switzerland, Belgium, Germany, Italy, Netherlands, United Kingdom, Portugal
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Healthy

United States
Abela Pharmaceuticals, Inc.
Ohio State University; University of California, Irvine; Dr. Mahajan's Hospital...

Unknown

Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury (ABELADRUG200)

Severe Head Trauma

United States
Iwate Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma
Amsterdam UMC, location VUmc

Unknown

Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial) (EXAMI)

Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).

Netherlands
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Terminated

The Efficacy of Spironolactone in Patients With Resistant Hypertension

Hypertension

United Kingdom
Sensimed AG
Clinique de Montchoisi, Lausanne, Switzerland

Completed

Use of an Ocular Telemetry Sensor in Diamox Treated Patients

Ocular Hypertension | Glaucoma

Switzerland
AstraZeneca

Completed

COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus (COMBAT)

Hypertension

Korea, Republic of
Centre Hospitalier Universitaire de Saint Etienne
Pharmaxis

Completed

Measurement of Exhaled Nitric Oxide (NO) and Bronchial Provocation Test With Mannitol as a Predictor of Response to Inhaled Corticosteroids in Chronic Cough (MANOTOUX)

Cough | Bronchial Hyperreactivity

France
CardioKine Inc.
Biogen; Cardiokine Biopharma, LLC

Withdrawn

International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia

Hypervolemic Hyponatremia
Azienda Ospedaliera San Camillo Forlanini

Completed

Comparison of Endothelial Dysfunction (BMS vs SES) in the Same Patient With Multiple Coronary Artery Lesions (CREDENTIAL)

Endothelial Dysfunction

Italy
Hadassah Medical Organization
Vaxil Therapeutics Ltd.

Withdrawn

A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies

Multiple Myeloma | Tumors

Israel
Novartis

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Hypertension

United States
University Hospital, Saarland

Unknown

Cognitive Impairment in Patients With Heart Failure (CogImpairHF)

Heart Failure | Cognitive Impairment

Germany

Search clinical trials for: C-type natriuretic peptide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations